SCHEMBL8658189

SCHEMBL8658189

CCc1ccc2c(c1)C(=O)c1cc[c]cc1C2=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.64
NPC1 O15118 4/20 0.64
RAB9A P51151 4/20 0.64
MAPT P10636 3/20 0.64
ALDH1A1 P00352 3/20 0.64
LMNA P02545 2/20 0.64
MAPK1 P28482 2/20 0.64
L3MBTL1 Q9Y468 2/20 0.64
MAOA P21397 2/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
CASP3 P42574 2/20 0.35
SENP8 Q96LD8 2/20 0.35
SENP7 Q9BQF6 2/20 0.35
SENP6 Q9GZR1 2/20 0.35
ATM Q13315 1/20 0.35
ELANE P08246 1/20 0.34
ESR1 P03372 1/20 0.33
UGT1A1 P22309 1/20 0.33
MAOB P27338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19396241 0.84 SMN1; SMN2 (0.88) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL11881427 0.84 SMN1; SMN2 (0.88) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
Water SCHEMBL28061572 0.80 NPC1 (0.96) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL13437909 0.80 SMN1; SMN2 (0.80) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL11892894 0.80 SMN1; SMN2 (0.80) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL29352712 0.78 NPC1 (1.00) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL36840 0.78 NPC1 (1.00) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
Anthraquinone SCHEMBL6310187 0.78 NPC1 (1.00) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL7148476 0.78 MEN1 (0.43) SMN1; SMN2NPC1RAB9AMAPTALDH1A1
SCHEMBL7318179 0.77 NPC1 (0.96) SMN1; SMN2NPC1RAB9AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5807837-A ADMINISTERING TO TREAT HIV INFECTIONS TO INHIBIT THE REPLICATION OF FOREIGN NUCLEIC ACIDS IN A NORMAL CELL SANKYO COMPANY, LIMITED (JP) 1998-09-15 US disclosed
US-5674856-A TREATMENT AND PROPHYLAXIS OF VIRAL INFECTIONS, INCLUDING AIDS AND TUMORS SANKYO COMPANY, LIMITED (JP) 1997-10-07 US disclosed
EP-0611075-B1 Modified oligodeoxyribonucleotides, their preparation and their therapeutic use SANKYO CO (JP) 1996-12-18 EP disclosed
EP-0611075-A1 Modified oligodeoxyribonucleotides, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-08-17 EP disclosed